260 related articles for article (PubMed ID: 16091473)
1. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
Takeshita F; Minakuchi Y; Nagahara S; Honma K; Sasaki H; Hirai K; Teratani T; Namatame N; Yamamoto Y; Hanai K; Kato T; Sano A; Ochiya T
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12177-82. PubMed ID: 16091473
[TBL] [Abstract][Full Text] [Related]
2. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; Kouno M; Honma K; Nagahara S; Hanai K; Sano A; Kato T; Terada M; Ochiya T
Nucleic Acids Res; 2004 Jul; 32(13):e109. PubMed ID: 15272050
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract][Full Text] [Related]
5. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
Meryet-Figuière M; Lecerf C; Varin E; Coll JL; Louis MH; Dutoit S; Giffard F; Blanc-Fournier C; Hedir S; Vigneron N; Brotin E; Pelletier L; Josserand V; Denoyelle C; Poulain L
Oncol Rep; 2017 Oct; 38(4):1949-1958. PubMed ID: 28791387
[TBL] [Abstract][Full Text] [Related]
6. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects.
Yuan Y; Makita N; Cao D; Mihara K; Kadomatsu K; Takei Y
Nucleic Acid Ther; 2015 Apr; 25(2):85-94. PubMed ID: 25692652
[TBL] [Abstract][Full Text] [Related]
7. Atelocollagen-mediated systemic DDS for nucleic acid medicines.
Hanai K; Takeshita F; Honma K; Nagahara S; Maeda M; Minakuchi Y; Sano A; Ochiya T
Ann N Y Acad Sci; 2006 Oct; 1082():9-17. PubMed ID: 17145919
[TBL] [Abstract][Full Text] [Related]
8. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
[TBL] [Abstract][Full Text] [Related]
9. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer.
Kawata E; Ashihara E; Kimura S; Takenaka K; Sato K; Tanaka R; Yokota A; Kamitsuji Y; Takeuchi M; Kuroda J; Tanaka F; Yoshikawa T; Maekawa T
Mol Cancer Ther; 2008 Sep; 7(9):2904-12. PubMed ID: 18790771
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
11. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
12. Identification of enhancer of zeste homolog 2 expression in peripheral circulating tumor cells in metastatic prostate cancer patients: a preliminary study.
Cho KS; Oh HY; Lee EJ; Hong SJ
Yonsei Med J; 2007 Dec; 48(6):1009-14. PubMed ID: 18159594
[TBL] [Abstract][Full Text] [Related]
13. Delivery of small interfering RNA with a synthetic collagen poly(Pro-Hyp-Gly) for gene silencing in vitro and in vivo.
Adachi T; Kawakami E; Ishimaru N; Ochiya T; Hayashi Y; Ohuchi H; Tanihara M; Tanaka E; Noji S
Dev Growth Differ; 2010 Oct; 52(8):693-9. PubMed ID: 20874713
[TBL] [Abstract][Full Text] [Related]
14. Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model.
Ito Y; Nozaki M; Sugitani K; Ashikari M; Hirano Y; Ogura Y
Ophthalmologica; 2013; 230(4):215-21. PubMed ID: 24080835
[TBL] [Abstract][Full Text] [Related]
15. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
16. Local and systemic delivery of siRNAs for oligonucleotide therapy.
Takeshita F; Hokaiwado N; Honma K; Banas A; Ochiya T
Methods Mol Biol; 2009; 487():83-92. PubMed ID: 19301643
[TBL] [Abstract][Full Text] [Related]
17. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
19. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
Fujimoto I; Takei Y
Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
[No Abstract] [Full Text] [Related]
20. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
